Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Nfe2l3 | Rat | 1,2-dichloroethane | affects expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | ethylene dichloride affects the expression of NFE2L3 mRNA | CTD | PMID:28960355 | Nfe2l3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of NFE2L3 mRNA | CTD | PMID:22206623 | Nfe2l3 | Rat | 17beta-estradiol | increases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | Estradiol results in increased expression of NFE2L3 mRNA | CTD | PMID:19484750 | Nfe2l3 | Rat | 17beta-estradiol | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of NFE2L3 mRNA; Estradiol results in increased expression of NFE2L3 more ... | CTD | PMID:25130429|PMID:28960787|PMID:31614463 | Nfe2l3 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | decreases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in decreased expression of NFE2L3 mRNA | CTD | PMID:31388691 | Nfe2l3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFE2L3 mRNA | CTD | PMID:24058054 | Nfe2l3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NFE2L3 mRNA | CTD | PMID:33387578 | Nfe2l3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFE2L3 mRNA | CTD | PMID:22574217 | Nfe2l3 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of NFE2L3 mRNA | CTD | PMID:30851411 | Nfe2l3 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of NFE2L3 mRNA | CTD | PMID:39298647 | Nfe2l3 | Rat | 5-fluorouracil | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of NFE2L3 mRNA | CTD | PMID:24737281 | Nfe2l3 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NFE2L3 mRNA | CTD | PMID:30047161 | Nfe2l3 | Rat | acrylamide | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of NFE2L3 mRNA | CTD | PMID:32763439 | Nfe2l3 | Rat | aflatoxin B1 | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of NFE2L3 mRNA | CTD | PMID:22100608 | Nfe2l3 | Rat | aflatoxin M1 | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of NFE2L3 mRNA | CTD | PMID:30928695 | Nfe2l3 | Rat | all-trans-retinoic acid | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of NFE2L3 mRNA | CTD | PMID:21934132|PMID:23724009|PMID:23830798 | Nfe2l3 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of NFE2L3 mRNA | CTD | PMID:30047161 | Nfe2l3 | Rat | antirheumatic drug | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of NFE2L3 mRNA | CTD | PMID:24449571 | Nfe2l3 | Rat | aristolochic acid A | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of NFE2L3 mRNA | CTD | PMID:33212167 | Nfe2l3 | Rat | arsane | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NFE2L3 more ... | CTD | PMID:32525701 | Nfe2l3 | Rat | arsenic atom | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NFE2L3 more ... | CTD | PMID:32525701 | Nfe2l3 | Rat | azathioprine | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of NFE2L3 mRNA | CTD | PMID:22623647 | Nfe2l3 | Rat | benzene | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Benzene results in increased expression of NFE2L3 mRNA | CTD | PMID:19162166 | Nfe2l3 | Rat | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of NFE2L3 mRNA | CTD | PMID:21839799 | Nfe2l3 | Rat | benzo[a]pyrene | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of NFE2L3 mRNA | CTD | PMID:32234424 | Nfe2l3 | Rat | benzo[a]pyrene | affects methylation | ISO | NFE2L3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of NFE2L3 promoter | CTD | PMID:27901495 | Nfe2l3 | Rat | benzo[a]pyrene | increases methylation | ISO | NFE2L3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of NFE2L3 exon | CTD | PMID:27901495 | Nfe2l3 | Rat | benzo[a]pyrene | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of NFE2L3 mRNA | CTD | PMID:20106945|PMID:21632981 | Nfe2l3 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NFE2L3 mRNA | CTD | PMID:20382639 | Nfe2l3 | Rat | beta-naphthoflavone | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of NFE2L3 mRNA | CTD | PMID:32151702 | Nfe2l3 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of NFE2L3 mRNA | CTD | PMID:31163220 | Nfe2l3 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Nfe2l3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NFE2L3 mRNA | CTD | PMID:25181051 | Nfe2l3 | Rat | bisphenol A | increases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of NFE2L3 mRNA | CTD | PMID:32156529 | Nfe2l3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NFE2L3 mRNA | CTD | PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487 | Nfe2l3 | Rat | bisphenol A | affects methylation | ISO | Nfe2l3 (Mus musculus) | 6480464 | bisphenol A affects the methylation of NFE2L3 promoter | CTD | PMID:27334623 | Nfe2l3 | Rat | butanal | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of NFE2L3 mRNA | CTD | PMID:26079696 | Nfe2l3 | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Nfe2l3 | Rat | cadmium dichloride | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of NFE2L3 mRNA | CTD | PMID:38568856 | Nfe2l3 | Rat | carbon nanotube | decreases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of NFE2L3 mRNA | CTD | PMID:25554681 | Nfe2l3 | Rat | chlorpyrifos | increases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of NFE2L3 mRNA | CTD | PMID:37019170 | Nfe2l3 | Rat | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of NFE2L3 mRNA | CTD | PMID:27899881 | Nfe2l3 | Rat | copper atom | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of NFE2L3 mRNA | CTD | PMID:24690739 | Nfe2l3 | Rat | copper(0) | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of NFE2L3 mRNA | CTD | PMID:24690739 | Nfe2l3 | Rat | copper(II) sulfate | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of NFE2L3 mRNA | CTD | PMID:19549813 | Nfe2l3 | Rat | crocidolite asbestos | increases methylation | ISO | NFE2L3 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in increased methylation of NFE2L3 5' UTR | CTD | PMID:29523930 | Nfe2l3 | Rat | CU-O LINKAGE | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of NFE2L3 mRNA | CTD | PMID:22077320 | Nfe2l3 | Rat | cyclophosphamide | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Cyclophosphamide metabolite results in decreased expression of NFE2L3 mRNA | CTD | PMID:24356939 | Nfe2l3 | Rat | cyclosporin A | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of NFE2L3 mRNA | CTD | PMID:20106945 | Nfe2l3 | Rat | dibutyl phthalate | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Nfe2l3 | Rat | dicrotophos | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of NFE2L3 mRNA | CTD | PMID:28302478 | Nfe2l3 | Rat | diethyl phthalate | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Nfe2l3 | Rat | diisobutyl phthalate | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Nfe2l3 | Rat | diisononyl phthalate | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Nfe2l3 | Rat | disodium selenite | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of NFE2L3 mRNA | CTD | PMID:18175754 | Nfe2l3 | Rat | disulfiram | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of NFE2L3 mRNA | CTD | PMID:24690739 | Nfe2l3 | Rat | dorsomorphin | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nfe2l3 | Rat | doxorubicin | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of NFE2L3 mRNA | CTD | PMID:29803840 | Nfe2l3 | Rat | entinostat | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | entinostat results in increased expression of NFE2L3 mRNA | CTD | PMID:27188386 | Nfe2l3 | Rat | ethyl methanesulfonate | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of NFE2L3 mRNA | CTD | PMID:23649840 | Nfe2l3 | Rat | gamma-hexachlorocyclohexane | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in decreased expression of NFE2L3 mRNA | CTD | PMID:24356939 | Nfe2l3 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of NFE2L3 mRNA | CTD | PMID:33387578 | Nfe2l3 | Rat | glyphosate | increases expression | EXP | | 6480464 | Glyphosate results in increased expression of NFE2L3 mRNA | CTD | PMID:38314887 | Nfe2l3 | Rat | GSK-J4 | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of NFE2L3 mRNA | CTD | PMID:29301935 | Nfe2l3 | Rat | herbicide | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Herbicides results in decreased expression of NFE2L3 mRNA | CTD | PMID:28711546 | Nfe2l3 | Rat | hydrogen peroxide | affects expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of NFE2L3 mRNA | CTD | PMID:20044591 | Nfe2l3 | Rat | indometacin | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Indomethacin results in increased expression of NFE2L3 mRNA | CTD | PMID:24737281 | Nfe2l3 | Rat | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of NFE2L3 mRNA | CTD | PMID:20080153 | Nfe2l3 | Rat | L-ascorbic acid | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Ascorbic Acid results in decreased expression of NFE2L3 mRNA; Ascorbic Acid results in decreased expression more ... | CTD | PMID:25130429 | Nfe2l3 | Rat | lipopolysaccharide | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of NFE2L3 mRNA | CTD | PMID:35811015 | Nfe2l3 | Rat | lipopolysaccharide | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NFE2L3 mRNA] | CTD | PMID:35811015 | Nfe2l3 | Rat | menadione | affects expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of NFE2L3 mRNA | CTD | PMID:20044591 | Nfe2l3 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of NFE2L3 mRNA | CTD | PMID:30047161 | Nfe2l3 | Rat | methyl methanesulfonate | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of NFE2L3 mRNA | CTD | PMID:23649840 | Nfe2l3 | Rat | methylmercury chloride | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of NFE2L3 mRNA | CTD | PMID:23179753 | Nfe2l3 | Rat | nickel atom | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Nickel results in increased expression of NFE2L3 mRNA | CTD | PMID:25583101 | Nfe2l3 | Rat | O-methyleugenol | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of NFE2L3 mRNA | CTD | PMID:32234424 | Nfe2l3 | Rat | ochratoxin A | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | ochratoxin A metabolite results in decreased expression of NFE2L3 mRNA; ochratoxin A results in decreased more ... | CTD | PMID:24356939 | Nfe2l3 | Rat | okadaic acid | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of NFE2L3 mRNA | CTD | PMID:38832940 | Nfe2l3 | Rat | ozone | multiple interactions | ISO | Nfe2l3 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NFE2L3 more ... | CTD | PMID:27106289 | Nfe2l3 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NFE2L3 mRNA | CTD | PMID:33387578 | Nfe2l3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of NFE2L3 mRNA | CTD | PMID:37995155 | Nfe2l3 | Rat | phenylmercury acetate | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nfe2l3 | Rat | PhIP | decreases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of NFE2L3 mRNA | CTD | PMID:15215175 | Nfe2l3 | Rat | propanal | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of NFE2L3 mRNA | CTD | PMID:26079696 | Nfe2l3 | Rat | quercetin | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of NFE2L3 mRNA | CTD | PMID:21632981 | Nfe2l3 | Rat | rac-lactic acid | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of NFE2L3 mRNA | CTD | PMID:30851411 | Nfe2l3 | Rat | resveratrol | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | resveratrol results in decreased expression of NFE2L3 mRNA; resveratrol results in decreased expression of NFE2L3 more ... | CTD | PMID:25130429|PMID:28960787 | Nfe2l3 | Rat | resveratrol | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of NFE2L3 mRNA | CTD | PMID:23557933 | Nfe2l3 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NFE2L3 mRNA] | CTD | PMID:35811015 | Nfe2l3 | Rat | SB 431542 | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nfe2l3 | Rat | sodium arsenate | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NFE2L3 more ... | CTD | PMID:32525701 | Nfe2l3 | Rat | sodium arsenite | decreases expression | ISO | Nfe2l3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of NFE2L3 mRNA | CTD | PMID:37682722 | Nfe2l3 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of NFE2L3 mRNA | CTD | PMID:30047161 | Nfe2l3 | Rat | sunitinib | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of NFE2L3 mRNA | CTD | PMID:31533062 | Nfe2l3 | Rat | temozolomide | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of NFE2L3 mRNA | CTD | PMID:31758290 | Nfe2l3 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of NFE2L3 mRNA | CTD | PMID:34492290 | Nfe2l3 | Rat | titanium dioxide | decreases methylation | ISO | Nfe2l3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of NFE2L3 gene | CTD | PMID:35295148 | Nfe2l3 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of NFE2L3 mRNA | CTD | PMID:33387578 | Nfe2l3 | Rat | trichostatin A | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of NFE2L3 mRNA | CTD | PMID:24935251 | Nfe2l3 | Rat | triphenyl phosphate | affects expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of NFE2L3 mRNA | CTD | PMID:37042841 | Nfe2l3 | Rat | tunicamycin | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of NFE2L3 mRNA | CTD | PMID:22378314 | Nfe2l3 | Rat | urethane | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of NFE2L3 mRNA | CTD | PMID:28818685 | Nfe2l3 | Rat | valproic acid | increases methylation | ISO | NFE2L3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NFE2L3 gene | CTD | PMID:29154799 | Nfe2l3 | Rat | valproic acid | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NFE2L3 mRNA | CTD | PMID:23179753|PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799 | Nfe2l3 | Rat | valproic acid | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nfe2l3 | Rat | valproic acid | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NFE2L3 mRNA | CTD | PMID:25192806 | Nfe2l3 | Rat | valproic acid | affects expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NFE2L3 mRNA | CTD | PMID:25979313 | Nfe2l3 | Rat | vincristine | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of NFE2L3 mRNA | CTD | PMID:23649840 | Nfe2l3 | Rat | vorinostat | increases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | vorinostat results in increased expression of NFE2L3 mRNA | CTD | PMID:27188386 | Nfe2l3 | Rat | zinc atom | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NFE2L3 mRNA | CTD | PMID:18593933 | Nfe2l3 | Rat | zinc(0) | multiple interactions | ISO | NFE2L3 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NFE2L3 mRNA | CTD | PMID:18593933 | Nfe2l3 | Rat | zoledronic acid | decreases expression | ISO | NFE2L3 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of NFE2L3 mRNA | CTD | PMID:20977926 | |






















